Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
about
Advances in the treatment of testicular cancerSurveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experienceEMT, CTCs and CSCs in tumor relapse and drug-resistanceContemporary management of stage I and II seminoma.Carboplatin AUC 10 for IGCCCG good prognosis metastatic seminoma.Low RBM3 protein expression correlates with clinical stage, prognostic classification and increased risk of treatment failure in testicular non-seminomatous germ cell cancer.Stage IIA and IIB testicular seminoma treated postorchiectomy with radiation therapy versus other approaches: a population-based analysis of 241 patients.Controversies in the management of clinical stage I testicular seminoma.Testicular seminoma clinical stage 1: treatment outcome on a routine care level.Second cancer risk and mortality in men treated with radiotherapy for stage I seminomaSEOM clinical guidelines for the management of germ cell testicular cancer (2016).Manipulating the epigenome for the treatment of urological malignancies.Minimizing toxicity in early-stage testicular cancer treatment.Disparities in Interpretation of Primary Testicular Germ Cell Tumor Pathology.Prognostic factors for tumor recurrence in patients with clinical stage I seminoma undergoing surveillance--protocol for a systematic review.Adjuvant chemotherapy and follow-up for recurrences in localized testicular cancerManagement of stage I testicular germ cell tumours.Management of clinical stage I testicular seminoma: active surveillance versus adjuvant chemotherapy.Evaluation of a prognostic model for risk of relapse in stage I seminoma surveillance.Epidermal growth factor receptor and epididymis invasion as prognostic biomarkers in clinical stage I testicular germ cell tumoursAdjuvant radiotherapy outcome of stage I testicular seminoma: a single institution study.Maintaining success, reducing treatment burden, focusing on survivorship: highlights from the third European consensus conference on diagnosis and treatment of germ-cell cancer.[Clinical stage I seminoma. Is surveillance a new therapy standard?].Late relapse of testis cancer.Patterns of care in the management of seminoma stage I: results from a European survey.The SWENOTECA group: A good example of continuous binational and multidisciplinary collaboration for patients with testicular cancer in Sweden and Norway.[Diagnosis, treatment and follow-up of testicular cancer].Recommendations for followup of stage I and II seminoma: The Princess Margaret Cancer Centre approach.Relevant risk of carboplatin underdosing in cancer patients with normal renal function using estimated GFR: lessons from a stage I seminoma cohort.Patterns of management and surveillance imaging amongst medical oncologists in Australia for stage I testicular cancer.[Importance of pathology for therapy planning of testicular germ cell tumors].Treatment outcome and patterns of relapse following adjuvant carboplatin for stage I testicular seminomatous germ-cell tumour: results from a 17-year UK experience.On thin ice: barriers to adoption of surveillance for patients with stage I testicular seminoma. Survey of US radiation oncologists.Testicular seminoma and non-seminoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upInternational phase IV validation study of an EORTC quality of life questionnaire for testicular cancer patients: the EORTC QLQ-TC26
P2860
Q26773626-4C768B0F-23EC-4AB8-9842-50C0D933A6ECQ26865862-27D4C678-9DF7-4FDA-A1C7-00CA2D0930B9Q28082935-EECE44EB-1125-4A57-992D-F6EDFD6BF74FQ30352886-B232BFB0-2D18-4934-B722-0011474D343EQ33403094-971ECE33-6F8C-4157-B633-92ECE303034EQ35219992-3E34F112-4CD5-4E17-B513-473CC4119BA0Q36575737-F3E039D0-9D3E-4A6C-9914-D2036FA13428Q36840698-5F068EF6-9162-4628-859C-9A331ABE1F70Q36985245-9C22FC31-91D8-49EA-A73A-C9ADBE7B8F4CQ37459549-38B0D50A-804E-4D4E-8893-53B5F3798C50Q37475147-903DEF11-9EBF-4C72-9789-448185A41EC2Q37524412-5E0FED0A-3E0A-48B6-952B-A466E7EEDDD8Q37982443-3C347257-E93D-4231-ABE4-5D6F6F2D0264Q38549210-16179251-CD0F-484E-AE59-1B0D0A491B08Q38673978-3DBD1333-34C6-4A83-9AAA-7C39FBF0572CQ38686649-C022F6A3-54B7-423F-A562-2E58601D1161Q38952121-FE490AB6-5B9D-4A6B-AFE5-318FCB16ABE6Q41732986-667E16CC-1D8C-417F-B49F-9D76B8CA3667Q42254931-2DAD83B4-AA9E-4912-BD49-1A8D04A379C9Q42315381-2DAD381A-ECFC-4AD4-85F4-99D013B2E5C5Q43080580-342A6A04-4D87-4CC6-86D9-4349E721700FQ43223621-C7D1C06D-1B51-4CD8-BA72-6E93F4433811Q44956406-D5977077-9F9D-4A48-8FE7-21409F14CB67Q46193220-4CB3EFE0-2631-45BF-B611-68DCE90DF9D0Q48030528-CBA34D84-EB90-4463-988E-6971C5E7326CQ49019282-E03D09A7-46E5-4B37-ACAB-015ECE86DCF8Q49503110-A6B9111A-DFE9-43D9-A52D-D58C0C3AFCDDQ49579824-5709456D-8002-4E40-82DA-65A02B3D4571Q51745955-D3EE718F-A0F7-41F2-84F0-363B8C23D0A4Q51802426-7793AD21-74DF-4DA8-AE45-901EE4C97170Q53055134-452A48EB-AE9F-435A-B908-36888CEAADCAQ53481484-89F783D4-DA6D-4FDF-9049-737AE6022AD7Q55083488-CBA218BB-1DF0-46F5-82A3-357A40316ED3Q57278891-54261364-8883-4530-A4FD-C6F126C29F86Q59127570-161886F0-A634-4704-A423-C30032DCC9EF
P2860
Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Management of seminomatous tes ...... testicular cancer study group.
@en
Management of seminomatous tes ...... testicular cancer study group.
@nl
type
label
Management of seminomatous tes ...... testicular cancer study group.
@en
Management of seminomatous tes ...... testicular cancer study group.
@nl
prefLabel
Management of seminomatous tes ...... testicular cancer study group.
@en
Management of seminomatous tes ...... testicular cancer study group.
@nl
P2093
P50
P356
P1476
Management of seminomatous tes ...... testicular cancer study group.
@en
P2093
Anna Laurell
Arne Solberg
Carl W Langberg
Eva K Cavallin-Ståhl
Gabriella Cohn-Cedermark
Olbjørn H Klepp
Olof Ståhl
Roy M Bremnes
Torgrim Tandstad
Ulrika K Stierner
P304
P356
10.1200/JCO.2010.30.1044
P407
P577
2011-01-04T00:00:00Z